nach oben

Erschienen in:

26.03.2020 | Original Investigation

Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases

verfasst von: Qiaoyun Zhao, Conghua Song, Ke Wang, Donghong Li, Yang Yang, Dongsheng Liu, Le Wang, Nanjin Zhou, Yong Xie

Erschienen in: Medical Microbiology and Immunology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Disease outcome is associated with virulence factors of Helicobacter pylori (H. pylori), which are partially attributed to the outer membrane protein (OMP). This study aimed to investigate the correlation between the four OMP genes (babA, oipA, sabA, and homB) and gastroduodenal diseases. One hundred and seventy-seven H. pylori strains were isolated from Chinese patients with different gastroduodenal diseases (49 chronic gastritis, 19 gastric ulcer, 33 gastric cancer, and 76 duodenal ulcer), 94 of which contained pathological information (41 superficial gastritis, 24 intestinal hyperplasia, and 29 gastric adenocarcinoma). The full-length amplification of babA, oipA, sabA, and homB genes was acquired and sequenced. Then, the genetic polymorphism was analyzed to compare with the reference strains from the GenBank database. Functional status and cluster analysis were also performed to evaluate the impact of genetic polymorphism on disease outcome. The prevalence of babA, oipA, sabA, and homB genes were 91.5%, 100%, 94.0%, and 95.5%, respectively. The four OMP genes were characterized by genetic polymorphism and in the status of positive selection (Ka/Ks> 1). The proportion of strains with functional status on for oipA and sabA gene was 100% and 76.2%, respectively. The sequences of four OMP genes were mainly clustered together with the East Asian references. The four OMP genes were not different in patients with gastroduodenal diseases and pathologic changes (P > 0.05). H. pylori babA, oipA, sabA, and homB genes were common in the Chinese populations, but did not seem to be involved in the development of gastroduodenal diseases.

Nur mit Berechtigung zugänglich

Fagoonee S, Pellicano R (2019) Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review. Infect Dis 51(6):399–408. https://doi.org/10.1080/23744235.2019.1588472CrossRef

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153(2):420–429. https://doi.org/10.1053/j.gastro.2017.04.022PubMedCrossRef

Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, Chen Y, Wang JB, Du YQ, Lu NH, Chinese Society of Gastroenterology CSGoHp, Peptic U (2018) Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter 23(2):e12475. https://doi.org/10.1111/hel.12475PubMedCrossRef

Munoz-Ramirez ZY, Mendez-Tenorio A, Kato I, Bravo MM, Rizzato C, Thorell K, Torres R, Aviles-Jimenez F, Camorlinga M, Canzian F, Torres J (2017) Whole genome sequence and phylogenetic analysis show Helicobacter pylori strains from Latin America have followed a unique evolution pathway. Front Cell Infect Microbiol 7:50. https://doi.org/10.3389/fcimb.2017.00050PubMedPubMedCentralCrossRef

Yamaoka Y, Kato M, Asaka M (2008) Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 47(12):1077–1083. https://doi.org/10.2169/internalmedicine.47.0975PubMedCrossRef

Cover TL (2016) Helicobacter pylori diversity and gastric cancer risk. MBio 7(1):e01869-01815. https://doi.org/10.1128/mBio.01869-15CrossRef

Ando T, Peek RM, Pride D, Levine SM, Takata T, Lee YC, Kusugami K, van der Ende A, Kuipers EJ, Kusters JG, Blaser MJ (2002) Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J Clin Microbiol 40(1):239–246. https://doi.org/10.1128/jcm.40.1.239-246.2002PubMedPubMedCentralCrossRef

Matsuo Y, Kido Y, Yamaoka Y (2017) Helicobacter pylori outer membrane protein-related pathogenesis. Toxins. https://doi.org/10.3390/toxins9030101PubMedPubMedCentralCrossRef

Oleastro M, Menard A (2013) The role of Helicobacter pylori outer membrane proteins in adherence and pathogenesis. Biology 2(3):1110–1134. https://doi.org/10.3390/biology2031110PubMedPubMedCentralCrossRef

10.

Whitmire JM, Merrell DS (2019) Helicobacter pylori genetic polymorphisms in gastric disease development. Adv Exp Med Biol 1149:173–194. https://doi.org/10.1007/5584_2019_365PubMedCrossRef

11.

Cover TL (2006) Role of Helicobacter pylori outer membrane proteins in gastroduodenal disease. J Infect Dis 194(10):1343–1345. https://doi.org/10.1086/508432PubMedCrossRef

12.

Hage N, Howard T, Phillips C, Brassington C, Overman R, Debreczeni J, Gellert P, Stolnik S, Winkler GS, Falcone FH (2015) Structural basis of Lewis(b) antigen binding by the Helicobacter pylori adhesin BabA. Sci Adv 1(7):e1500315. https://doi.org/10.1126/sciadv.1500315PubMedPubMedCentralCrossRef

13.

Al-Maleki AR, Loke MF, Lui SY, Ramli NSK, Khosravi Y, Ng CG, Venkatraman G, Goh KL, Ho B, Vadivelu J (2017) Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro. Cell Microbiol. https://doi.org/10.1111/cmi.12771PubMedCrossRef

14.

Benktander J, Barone A, Johansson MM, Teneberg S (2018) Helicobacter pylori SabA binding gangliosides of human stomach. Virulence 9(1):738–751. https://doi.org/10.1080/21505594.2018.1440171PubMedPubMedCentralCrossRef

15.

Oleastro M, Cordeiro R, Ferrand J, Nunes B, Lehours P, Carvalho-Oliveira I, Mendes AI, Penque D, Monteiro L, Megraud F, Menard A (2008) Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis 198(9):1379–1387. https://doi.org/10.1086/592166PubMedCrossRef

16.

Odenbreit S, Swoboda K, Barwig I, Ruhl S, Boren T, Koletzko S, Haas R (2009) Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect Immun 77(9):3782–3790. https://doi.org/10.1128/IAI.00364-09PubMedPubMedCentralCrossRef

17.

Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY (2006) Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55(6):775–781. https://doi.org/10.1136/gut.2005.083014PubMedPubMedCentralCrossRef

18.

Su YL, Huang HL, Huang BS, Chen PC, Chen CS, Wang HL, Lin PH, Chieh MS, Wu JJ, Yang JC, Chow LP (2016) Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer. Sci Rep 6:36442. https://doi.org/10.1038/srep36442PubMedPubMedCentralCrossRef

19.

Yilmaz N, Koruk Ozer M (2019) The prevalence of Helicobacter pylori babA, homB, aspA, and sabA genes and its relationship with clinical outcomes in Turkey. Can J Gastroenterol Hepatol 2019:1271872. https://doi.org/10.1155/2019/1271872PubMedPubMedCentralCrossRef

20.

Liu DS, Wang YH, Zeng ZR, Zhang ZY, Lu H, Xu JM, Du YQ, Li Y, Wang JB, Xu SP, Chen Y, Lan CH, Cheng H, Jiang MD, Zhang LX, Huo LJ, Chen SY, Zhang GX, Wu KC, Zhu X, Chen YX, Zhu Y, Shu X, Xie Y, Lu NH (2018) Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. Clin Microbiol Infect 24(7):780.e785–780, e788. https://doi.org/10.1016/j.cmi.2017.11.010

21.

Zhang Z, Li J, Yu J (2006) Computing Ka and Ks with a consideration of unequal transitional substitutions. BMC Evol Biol 6:44. https://doi.org/10.1186/1471-2148-6-44PubMedPubMedCentralCrossRef

22.

Kudo T, Nurgalieva ZZ, Conner ME, Crawford S, Odenbreit S, Haas R, Graham DY, Yamaoka Y (2004) Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol 42(5):2279–2281. https://doi.org/10.1128/jcm.42.5.2279-2281.2004PubMedPubMedCentralCrossRef

23.

Kawai M, Furuta Y, Yahara K, Tsuru T, Oshima K, Handa N, Takahashi N, Yoshida M, Azuma T, Hattori M, Uchiyama I, Kobayashi I (2011) Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes. BMC Microbiol 11:104. https://doi.org/10.1186/1471-2180-11-104PubMedPubMedCentralCrossRef

24.

Gutierrez-Escobar AJ, Trujillo E, Acevedo O, Bravo MM (2017) Phylogenomics of Colombian Helicobacter pylori isolates. Gut Pathog 9:52. https://doi.org/10.1186/s13099-017-0201-1PubMedPubMedCentralCrossRef

25.

Adrian J, Bonsignore P, Hammer S, Frickey T, Hauck CR (2019) Adaptation to host-specific bacterial pathogens drives rapid evolution of a human innate immune receptor. Curr Biol 29(4):616–630.e615. https://doi.org/10.1016/j.cub.2019.01.058PubMedCrossRef

26.

Vaziri F, Najar Peerayeh S, Alebouyeh M, Mirzaei T, Yamaoka Y, Molaei M, Maghsoudi N, Zali MR (2013) Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders. World J Gastroenterol 19(34):5685–5692. https://doi.org/10.3748/wjg.v19.i34.5685PubMedPubMedCentralCrossRef

27.

Torres K, Valderrama E, Sayegh M, Ramirez JL, Chiurillo MA (2014) Study of the oipA genetic diversity and EPIYA motif patterns in cagA-positive Helicobacter pylori strains from Venezuelan patients with chronic gastritis. Microb Pathog 76:26–32. https://doi.org/10.1016/j.micpath.2014.09.006PubMedCrossRef

28.

Kim SY, Woo CW, Lee YM, Son BR, Kim JW, Chae HB, Youn SJ, Park SM (2001) Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. J Korean Med Sci 16(5):579–584. https://doi.org/10.3346/jkms.2001.16.5.579PubMedPubMedCentralCrossRef

29.

Shao L, Takeda H, Fukui T, Mabe K, Han J, Kawata S, Ootani K, Fukao A (2010) Genetic diversity of the Helicobacter pylori sialic acid-binding adhesin (sabA) gene. Biosci Trends 4(5):249–253PubMed

30.

Dossumbekova A, Prinz C, Mages J, Lang R, Kusters JG, Van Vliet AH, Reindl W, Backert S, Saur D, Schmid RM, Rad R (2006) Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis 194(10):1346–1355. https://doi.org/10.1086/508426PubMedCrossRef

31.

Kim JY, Kim N, Nam RH, Suh JH, Chang H, Lee JW, Kim YS, Kim JM, Choi JW, Park JG, Lee YS, Lee DH, Jung HC (2014) Association of polymorphisms in virulence factor of Helicobacter pylori and gastroduodenal diseases in South Korea. J Gastroenterol Hepatol 29(5):984–991. https://doi.org/10.1111/jgh.12509PubMedCrossRef

32.

Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C (1999) Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96(22):12778–12783. https://doi.org/10.1073/pnas.96.22.12778PubMedCrossRefPubMedCentral

33.

Oleastro M, Cordeiro R, Yamaoka Y, Queiroz D, Megraud F, Monteiro L, Menard A (2009) Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog 1(1):12. https://doi.org/10.1186/1757-4749-1-12PubMedPubMedCentralCrossRef

34.

Souod N, Sarshar M, Dabiri H, Momtaz H, Kargar M, Mohammadzadeh A, Abdi S (2015) The study of the oipA and dupA genes in Helicobacter pylori strains and their relationship with different gastroduodenal diseases. Gastroenterol Hepatol Bed Bench 8(Suppl 1):S47–53PubMedPubMedCentral

35.

Chen MY, He CY, Meng X, Yuan Y (2013) Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. World J Gastroenterol 19(26):4242–4251. https://doi.org/10.3748/wjg.v19.i26.4242PubMedPubMedCentralCrossRef

36.

Dabiri H, Jafari F, Baghaei K, Shokrzadeh L, Abdi S, Pourhoseingholi MA, Mohammadzadeh A (2017) Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microb Pathog 105:226–230. https://doi.org/10.1016/j.micpath.2017.02.018PubMedCrossRef

37.

Abadi ATB (2017) Strategies used by Helicobacter pylori to establish persistent infection. World J Gastroenterol 23(16):2870–2882. https://doi.org/10.3748/wjg.v23.i16.2870PubMedPubMedCentralCrossRef

38.

Gangwer KA, Shaffer CL, Suerbaum S, Lacy DB, Cover TL, Bordenstein SR (2010) Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. J Bacteriol 192(23):6126–6135. https://doi.org/10.1128/JB.01081-10PubMedPubMedCentralCrossRef

39.

Duncan SS, Valk PL, McClain MS, Shaffer CL, Metcalf JA, Bordenstein SR, Cover TL (2013) Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes. PLoS ONE 8(1):e55120. https://doi.org/10.1371/journal.pone.0055120PubMedPubMedCentralCrossRef

40.

Soto-Giron MJ, Ospina OE, Massey SE (2015) Elevated levels of adaption in Helicobacter pylori genomes from Japan; a link to higher incidences of gastric cancer? Evol Med Public Health 1:88–105. https://doi.org/10.1093/emph/eov005CrossRef

41.

Yamaoka Y, Kwon DH, Graham DY (2000) A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97(13):7533–7538. https://doi.org/10.1073/pnas.130079797PubMedCrossRefPubMedCentral

42.

Oh JD, Kling-Backhed H, Giannakis M, Xu J, Fulton RS, Fulton LA, Cordum HS, Wang C, Elliott G, Edwards J, Mardis ER, Engstrand LG, Gordon JI (2006) The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci USA 103(26):9999–10004. https://doi.org/10.1073/pnas.0603784103PubMedCrossRefPubMedCentral

43.

Sheu BS, Odenbreit S, Hung KH, Liu CP, Sheu SM, Yang HB, Wu JJ (2006) Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol 101(1):36–44. https://doi.org/10.1111/j.1572-0241.2006.00358.xPubMedCrossRef

Titel: Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases
verfasst von: Qiaoyun Zhao
Conghua Song
Ke Wang
Donghong Li
Yang Yang
Dongsheng Liu
Le Wang
Nanjin Zhou
Yong Xie
Publikationsdatum: 26.03.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Medical Microbiology and Immunology / Ausgabe 5/2020
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-020-00666-2

The effect of KIR and HLA polymorphisms on dengue infection and disease severity in northeastern Thais

Original Investigation

Correction to: A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis

Correction

Correction to: Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century

Correction

Association of serum C-reactive protein level and polymorphisms with susceptibility to dengue infection and severe clinical outcome among eastern Indian patients

Original Investigation

Evaluation of Salmonella Typhi antigen YncE alongside HlyE for the detection of typhoid fever and its carriers

Original Investigation

Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+Aspergillus fumigatus specific T-cell quantification

Original Investigation

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Antibiotika bei Bakteriämie – 7 versus 14 Tage

21.01.2025
Sepsis
Nachrichten

Eine Bakteriämie lässt sich mit einer einwöchigen Antibiotikatherapie zumeist gut in den Griff bekommen: Die Sterberate ist nicht höher als unter zweiwöchiger Behandlung, zeigt eine Vergleichsstudie mit hospitalisierten Erkrankten. Allerdings muss die Therapie bei fast jedem Vierten verlängert werden.

"Die Erektionsstörung ist keine isolierte Erkrankung"

21.01.2025
Erektile Dysfunktion
Podcast

Werden Erektionsstörungen gut behandelt (und das ist möglich), steigt die Lebensqualität enorm. Tipps für eine gute Kommunikation mit den Patienten gibt Androloge Dr. med. Jann-Frederik Cremers in dieser Folge. Welche Fragen sollten gestellt und an welche Ursachen gedacht werden? Und was ist zu tun, wenn PDE-5-Hemmer und Lebensstilveränderungen nicht ausreichend wirken?

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

20.01.2025
Koronare Herzerkrankung
Nachrichten

Der Lp(a)-Wert kann dazu beitragen, bei stabilen Patienten mit neu aufgetretenen Thoraxschmerzen und ohne KHK-Diagnose die Wahrscheinlichkeit für das Vorliegen von Koronarstenosen abzuschätzen.

Finerenon bei eGFR-Verlust nicht gleich absetzen!

20.01.2025
Chronische Herzinsuffizienz
Nachrichten

Der Mineralokortikoid-Rezeptor-Antagonist Finerenon verbessert die Prognose bei Herzinsuffizienz mit leicht reduzierter oder erhaltener Ejektionsfraktion. Ein Rückgang der eGFR zu Beginn der Therapie scheint diese Wirkung nicht wesentlich zu mindern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases

Abstract

Weitere Artikel der Ausgabe 5/2020

The effect of KIR and HLA polymorphisms on dengue infection and disease severity in northeastern Thais

Correction to: A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis

Correction to: Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century

Association of serum C-reactive protein level and polymorphisms with susceptibility to dengue infection and severe clinical outcome among eastern Indian patients

Evaluation of Salmonella Typhi antigen YncE alongside HlyE for the detection of typhoid fever and its carriers

Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154+Aspergillus fumigatus specific T-cell quantification

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Neu im Fachgebiet Innere Medizin

Antibiotika bei Bakteriämie – 7 versus 14 Tage

"Die Erektionsstörung ist keine isolierte Erkrankung"

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

Finerenon bei eGFR-Verlust nicht gleich absetzen!

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten